Lluís Peri Cusi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lluís Peri Cusi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Alcaraz
Uro-Oncology Unit, Department of Urology, Hospital Clinic de Barcelona, 08036 Barcelona, Spain
5 shared publications - Mireia Musquera
Department of Medical al Surgical Specialties, Universitat de Barcelona, Spain
3 shared publications Agustín Franco de Castro
Urology Department, Hospital Clinic, Barcelona, Spain
2 shared publicationsLuis López‐Fando
Urology Department, Hospital Ramón y Cajal, Madrid, Spain
2 shared publicationsMiguel Ángel Jiménez Cidre
Urology Department, Hospital Ramón y Cajal, Madrid, Spain
2 shared publicationsA. Ruiz Arranz
1 shared publication
Latest Publications
- Open Access
- 29 October 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 775-784
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study
Purpose Lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated with a high clinical, economic and humanistic burden. Several surgical techniques are available for the treatment of LUTS/BPH; thus, the aim of this study was to describe and explore the variability in the use of surgical procedures among Spanish hospitals. Methods The REVALURO was a retrospective, observational study conducted by collecting data from the clinical records of patients with LUTS/BPH aged ≥ 35 years, from 5 national reference hospitals, who were surgically treated between 2018 and 2022. Results Among the 3038 patients who underwent 3084 surgeries, 66% were invasive (2018: 57.5%, 2022: 71.5%), 22% were minimally invasive (MISTs) (2018: 20.7%, 2022: 20.2%) and 12% were highly invasive (2018: 21.8%, 2022: 8.4%). A total of 22.4% of patients’ complications, with a maximum incidence of 28.6% (open prostatectomy) and a minimum 0.8% (water vapor thermal therapy (WVTT)] (p < 0.001). The reintervention rate was 1.5% over the study period. The median length of hospital stay after surgery increased from 0 days (interquartile range [IQR]: 0) with WVTT to 5 days (IQR: 4–8) with open prostatectomy (p < 0.001). Conclusion Trends in surgical treatment showed that the use of invasive techniques increased, while the use of highly invasive techniques decreased, and the use of MISTs remained constant. However, given the heterogeneity among hospitals, national clinical guidelines and recommendations are needed to guide the decision on which technique should be used and to homogenize the criteria.
- 29 October 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (3) , 775-784
Open AccessA real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study
Purpose Lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) is a growing condition in males associated with a high clinical, economic and humanistic burden. Several surgical techniques are available for the treatment of LUTS/BPH; thus, the aim of this study was to describe and explore the variability in the use of surgical procedures among Spanish hospitals. Methods The REVALURO was a retrospective, observational study conducted by collecting data from the clinical records of patients with LUTS/BPH aged ≥ 35 years, from 5 national reference hospitals, who were surgically treated between 2018 and 2022. Results Among the 3038 patients who underwent 3084 surgeries, 66% were invasive (2018: 57.5%, 2022: 71.5%), 22% were minimally invasive (MISTs) (2018: 20.7%, 2022: 20.2%) and 12% were highly invasive (2018: 21.8%, 2022: 8.4%). A total of 22.4% of patients’ complications, with a maximum incidence of 28.6% (open prostatectomy) and a minimum 0.8% (water vapor thermal therapy (WVTT)] (p < 0.001). The reintervention rate was 1.5% over the study period. The median length of hospital stay after surgery increased from 0 days (interquartile range [IQR]: 0) with WVTT to 5 days (IQR: 4–8) with open prostatectomy (p < 0.001). Conclusion Trends in surgical treatment showed that the use of invasive techniques increased, while the use of highly invasive techniques decreased, and the use of MISTs remained constant. However, given the heterogeneity among hospitals, national clinical guidelines and recommendations are needed to guide the decision on which technique should be used and to homogenize the criteria.
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1793
Uterine transplantation: First case
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S1793
Uterine transplantation: First case
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S485-S486
Analysis of primari non-function, delayed graft function and overall graft survival for expanded criteria donors’ kidneys
- 1 June 2021
- Published by Elsevier in European Urology
- Vol. 79, S485-S486
Analysis of primari non-function, delayed graft function and overall graft survival for expanded criteria donors’ kidneys
- 1 December 2020
- Published by S. Karger AG in Urologia Internationalis
- Vol. 105 (1-2) , 148-154
Technique Description and Outcomes of Robotic Transvaginal-Assisted Living Donor Kidney Transplantation
Objective: The aim of the study was to describe the surgical technique of totally robotic kidney transplantation with transvaginal insertion and to assess its safety and feasibility. Methods: It is a prospective analysis of the first 5 cases of robotic kidney transplantation with transvaginal insertion. Robotic-assisted kidney transplantation was performed after transvaginal insertion of a living donor kidney graft. Donor’s and recipient’s characteristics, intraoperative variables, postoperative complications, and surgical outcomes were assessed. Results: The median operative time was 220 min. Mean rewarming ischemia time of 53 min, with immediate diuresis. No intraoperative complications were observed. Mean hospitalization period was 9 days, with mean Cr of 1.5 mg/dL at discharge. Conclusions: Robotic kidney transplantation with transvaginal insertion is feasible and safe. A greater number of procedures are required to confirm the results of this new technique.
- 1 December 2020
- Published by S. Karger AG in Urologia Internationalis
- Vol. 105 (1-2) , 148-154
Technique Description and Outcomes of Robotic Transvaginal-Assisted Living Donor Kidney Transplantation
Objective: The aim of the study was to describe the surgical technique of totally robotic kidney transplantation with transvaginal insertion and to assess its safety and feasibility. Methods: It is a prospective analysis of the first 5 cases of robotic kidney transplantation with transvaginal insertion. Robotic-assisted kidney transplantation was performed after transvaginal insertion of a living donor kidney graft. Donor’s and recipient’s characteristics, intraoperative variables, postoperative complications, and surgical outcomes were assessed. Results: The median operative time was 220 min. Mean rewarming ischemia time of 53 min, with immediate diuresis. No intraoperative complications were observed. Mean hospitalization period was 9 days, with mean Cr of 1.5 mg/dL at discharge. Conclusions: Robotic kidney transplantation with transvaginal insertion is feasible and safe. A greater number of procedures are required to confirm the results of this new technique.
- 8 January 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 38 (2) , 764-769
Validation of a 3 day electronic bladder diary as an app for smart‐phone
Aim: To validate an electronic 3‐day bladder diary (BD) as an easy‐to‐use app for smart‐phone (eDM3d).Methods: Descriptive and cross‐sectional prospective study. One hundred and thirty‐six patients with overactive bladder syndrome (OABs) or nocturia who had a smart‐phone and attended the urology clinics of a tertiary hospital from June to November 2017 were included. Patients filled the eDM3d (test) and the Spanish validated paper BD (DM3d) and questionnaires ICIQ‐UISF and BASQ during the first week. Two weeks later, they repeated the eDM3d (retest). We assessed feasibility of the eDM3d (percentage of variables completed), test‐retest reliability (qualitative variables: McNemar test; quantitative variables: ICC), paper‐app correlation (qualitative variables: Kappa index; quantitative variables: ICC) and convergent validity (correlation between eDM3d and questionnaires, Spearman's rank test). Patients answered a question about satisfaction: “If you had to repeat a BD again, would you choose paper or the app version?”Results: One hundred and twenty‐three (90.4%) participants completed all the variables of the first eDM3d. There were no significant differences in the proportion of patients classified as positive for each symptom between test and retest. ICC ranged from 0.73 to 0.94 for all variables (P < 0.001) in the test‐retest assessment. Paper‐app correlation was good to excellent for all variables (ICC 0.76‐0.95, P < 0.001; Kappa index 0.56‐0.84, P < 0.001). Correlation between the eDM3d and the questionnaires ranged from 0.23 to 0.6 (P < 0.01). 120 (88.2%) patients would choose the eDM3d if they had to repeat a BD.Conclusion: The eDM3d presents suitable feasibility, reliability, and validity to assess patients with OABs or nocturia who have a smart‐phone.
- 8 January 2019
- Published by Wiley in Neurourology and Urodynamics
- Vol. 38 (2) , 764-769
Validation of a 3 day electronic bladder diary as an app for smart‐phone
Aim: To validate an electronic 3‐day bladder diary (BD) as an easy‐to‐use app for smart‐phone (eDM3d).Methods: Descriptive and cross‐sectional prospective study. One hundred and thirty‐six patients with overactive bladder syndrome (OABs) or nocturia who had a smart‐phone and attended the urology clinics of a tertiary hospital from June to November 2017 were included. Patients filled the eDM3d (test) and the Spanish validated paper BD (DM3d) and questionnaires ICIQ‐UISF and BASQ during the first week. Two weeks later, they repeated the eDM3d (retest). We assessed feasibility of the eDM3d (percentage of variables completed), test‐retest reliability (qualitative variables: McNemar test; quantitative variables: ICC), paper‐app correlation (qualitative variables: Kappa index; quantitative variables: ICC) and convergent validity (correlation between eDM3d and questionnaires, Spearman's rank test). Patients answered a question about satisfaction: “If you had to repeat a BD again, would you choose paper or the app version?”Results: One hundred and twenty‐three (90.4%) participants completed all the variables of the first eDM3d. There were no significant differences in the proportion of patients classified as positive for each symptom between test and retest. ICC ranged from 0.73 to 0.94 for all variables (P < 0.001) in the test‐retest assessment. Paper‐app correlation was good to excellent for all variables (ICC 0.76‐0.95, P < 0.001; Kappa index 0.56‐0.84, P < 0.001). Correlation between the eDM3d and the questionnaires ranged from 0.23 to 0.6 (P < 0.01). 120 (88.2%) patients would choose the eDM3d if they had to repeat a BD.Conclusion: The eDM3d presents suitable feasibility, reliability, and validity to assess patients with OABs or nocturia who have a smart‐phone.
- 22 January 2018
- Published by Wiley in Neurourology and Urodynamics
- Vol. 37 (5) , 1717-1723
Development and feasibility assessment of a 3 day electronic bladder diary as an app for smart‐phone
Aims: To develop a 3 day bladder diary (BD) as an easy‐to‐use application for smart‐phone (eDM3d). To test its feasibility and acceptance in a reduced number of patients.Methods: An external agency developed the eDM3d following the structure of the Spanish validated 3 day BD (DM3d©), which includes a frequency‐volume chart, the assessment of the grade of urgency, the incontinence events and fluid intake. The eDM3d consisted in a main interface of four buttons (“wake up,” “go to bed,” “urinate,” “drink”) which had to be clicked to create an event. Results were automatically transferred to an internet server to obtain an electronic report. We recruited 25 patients with overactive bladder syndrome or nocturia and previous experience on paper BD. They were asked to complete the eDM3d. Finally, a direct question about satisfaction was answered: “If you had to complete a BD again, would you choose the paper or the app version?”Results: Three patients (12%) did not complete the eDM3d, 1 patient (4%) completed 2 days of the eDM3d and did not register volumes of micturition nor fluid intake, 1 patient (4%) completed all 2 days variables and 20 patients (80%) completed all 3 day variables. Regarding satisfaction, 19 patients (86.4%) would choose the app version, 2 patients (9.1%) would choose a paper version and 1 patient (4.5%) would choose either indistinctly.Conclusions: The eDM3d is a useful tool easily filled in by patients with a high satisfaction rate. Adequate validation of the eDM3d is required.
- 22 January 2018
- Published by Wiley in Neurourology and Urodynamics
- Vol. 37 (5) , 1717-1723
Development and feasibility assessment of a 3 day electronic bladder diary as an app for smart‐phone
Aims: To develop a 3 day bladder diary (BD) as an easy‐to‐use application for smart‐phone (eDM3d). To test its feasibility and acceptance in a reduced number of patients.Methods: An external agency developed the eDM3d following the structure of the Spanish validated 3 day BD (DM3d©), which includes a frequency‐volume chart, the assessment of the grade of urgency, the incontinence events and fluid intake. The eDM3d consisted in a main interface of four buttons (“wake up,” “go to bed,” “urinate,” “drink”) which had to be clicked to create an event. Results were automatically transferred to an internet server to obtain an electronic report. We recruited 25 patients with overactive bladder syndrome or nocturia and previous experience on paper BD. They were asked to complete the eDM3d. Finally, a direct question about satisfaction was answered: “If you had to complete a BD again, would you choose the paper or the app version?”Results: Three patients (12%) did not complete the eDM3d, 1 patient (4%) completed 2 days of the eDM3d and did not register volumes of micturition nor fluid intake, 1 patient (4%) completed all 2 days variables and 20 patients (80%) completed all 3 day variables. Regarding satisfaction, 19 patients (86.4%) would choose the app version, 2 patients (9.1%) would choose a paper version and 1 patient (4.5%) would choose either indistinctly.Conclusions: The eDM3d is a useful tool easily filled in by patients with a high satisfaction rate. Adequate validation of the eDM3d is required.
- 1 January 2016
- Published by SAGE Publications in Urologia Journal
- Vol. 83 (1_suppl) , 5-10
Fighting Urinary Tract Infections with Antibiotic and Non-Antibiotic Therapies
Urinary tract infections (UTIs) place a considerable burden on the patient and are associated with substantial economic cost. Treatment of UTIs is mainly achieved using antibiotics, however, the rise in antibiotic resistance is concerning and the use of non-antimicrobial prophylaxis offers alternative treatment methods.
- 1 January 2016
- Published by SAGE Publications in Urologia Journal
- Vol. 83 (1_suppl) , 5-10
Fighting Urinary Tract Infections with Antibiotic and Non-Antibiotic Therapies
Urinary tract infections (UTIs) place a considerable burden on the patient and are associated with substantial economic cost. Treatment of UTIs is mainly achieved using antibiotics, however, the rise in antibiotic resistance is concerning and the use of non-antimicrobial prophylaxis offers alternative treatment methods.
- Open Access
- 1 August 2005
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 29 (7) , 708-710
Priapismo de alto flujo y larga evolución: Presentación de un caso y propuesta de algoritmo diagnóstico y tratamiento
- 1 August 2005
- Published by Elsevier in Actas Urológicas Españolas
- Vol. 29 (7) , 708-710
Open AccessPriapismo de alto flujo y larga evolución: Presentación de un caso y propuesta de algoritmo diagnóstico y tratamiento